SEBASTIANI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.271
EU - Europa 25.494
AS - Asia 14.691
SA - Sud America 2.137
AF - Africa 386
OC - Oceania 121
Continente sconosciuto - Info sul continente non disponibili 26
Totale 72.126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.663
IT - Italia 14.262
SG - Singapore 4.520
GB - Regno Unito 4.235
CN - Cina 4.030
HK - Hong Kong 1.758
BR - Brasile 1.594
VN - Vietnam 1.489
SE - Svezia 1.334
DE - Germania 933
FR - Francia 909
FI - Finlandia 835
UA - Ucraina 659
RU - Federazione Russa 580
KR - Corea 531
TR - Turchia 524
NL - Olanda 520
IN - India 366
JP - Giappone 292
ID - Indonesia 285
MX - Messico 251
CA - Canada 250
BG - Bulgaria 248
IE - Irlanda 206
AR - Argentina 189
PL - Polonia 131
ZA - Sudafrica 130
BD - Bangladesh 123
IQ - Iraq 112
AU - Australia 110
PK - Pakistan 95
CH - Svizzera 89
EC - Ecuador 83
ES - Italia 80
AE - Emirati Arabi Uniti 76
CL - Cile 72
LT - Lituania 72
MY - Malesia 66
TN - Tunisia 66
BE - Belgio 63
CO - Colombia 62
RO - Romania 58
SA - Arabia Saudita 57
AT - Austria 53
EG - Egitto 46
VE - Venezuela 46
PH - Filippine 44
IR - Iran 41
MA - Marocco 38
TH - Thailandia 35
BZ - Belize 32
JO - Giordania 31
UZ - Uzbekistan 31
NP - Nepal 30
PE - Perù 30
PT - Portogallo 29
TW - Taiwan 27
KE - Kenya 25
DZ - Algeria 24
PY - Paraguay 24
DK - Danimarca 22
CZ - Repubblica Ceca 21
EU - Europa 21
AZ - Azerbaigian 20
HU - Ungheria 20
GR - Grecia 19
BO - Bolivia 18
IL - Israele 16
UY - Uruguay 16
AL - Albania 15
LV - Lettonia 15
OM - Oman 15
LB - Libano 14
DO - Repubblica Dominicana 13
RS - Serbia 13
BY - Bielorussia 11
HN - Honduras 11
HR - Croazia 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
PA - Panama 10
TT - Trinidad e Tobago 10
KG - Kirghizistan 9
LU - Lussemburgo 9
CY - Cipro 8
ET - Etiopia 8
JM - Giamaica 8
KW - Kuwait 7
MD - Moldavia 7
QA - Qatar 7
SN - Senegal 7
KZ - Kazakistan 5
NI - Nicaragua 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
CI - Costa d'Avorio 4
CR - Costa Rica 4
GT - Guatemala 4
KH - Cambogia 4
MK - Macedonia 4
Totale 72.037
Salva come PNG Salva come JPEG
Città #
Singapore 3.115
Santa Clara 2.938
Southend 2.843
Fairfield 2.496
Ashburn 2.313
Hong Kong 1.712
Chandler 1.403
Woodbridge 1.391
Hefei 1.383
Houston 1.151
Milan 1.089
Rome 973
San Jose 957
Jacksonville 944
Wilmington 893
Seattle 888
Chicago 877
Ann Arbor 783
Cambridge 781
London 734
Los Angeles 693
Nyköping 687
Dearborn 669
Helsinki 633
Beijing 624
The Dalles 494
Seoul 469
Ho Chi Minh City 436
Council Bluffs 434
Salt Lake City 400
Hanoi 376
Modena 373
New York 314
San Diego 263
Bologna 253
Florence 253
Izmir 244
Naples 236
Princeton 234
Sofia 234
Lauterbourg 211
Jakarta 198
Turin 195
Dallas 192
Redwood City 190
Moscow 186
Eugene 182
Palermo 182
Bari 176
Tampa 173
Elk Grove Village 162
Buffalo 161
Shanghai 161
Tokyo 157
Dublin 153
São Paulo 153
Des Moines 139
Genoa 138
Frankfurt am Main 136
Catania 120
Verona 116
Bremen 112
Cagliari 99
Padova 99
Columbus 96
Falls Church 91
Orem 90
Sterling 87
Da Nang 84
Mexico City 78
Boardman 76
Munich 76
Brescia 73
Guangzhou 73
Atlanta 69
Toronto 68
Lancaster 67
Manchester 67
Parma 64
Kent 63
Brooklyn 60
Warsaw 57
Haiphong 56
Chennai 55
Redondo Beach 55
Detroit 53
Miami 53
Dulles 49
Johannesburg 49
Monza 49
Phoenix 49
Denver 48
Perth 47
Salerno 46
Amsterdam 45
Bergamo 45
Montreal 45
Mumbai 44
Norwalk 44
Perugia 44
Totale 43.989
Salva come PNG Salva come JPEG
Nome #
Prevalenza delle epatiti nelle malattie reumatiche 6.875
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.817
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.328
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.276
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 935
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 774
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 563
Semeiotica dell'articolazione temporo-mandibolare 543
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 466
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 444
B-cells and mixed cryoglobulinemia 434
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 428
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 405
Capillaroscopia del letto periungueale in pazienti affetti da artrite psoriasica e spondilite anchilosante. 394
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 392
Thymus alterations and systemic sclerosis 383
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 372
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 369
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 368
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 363
Heart involvement and systemic sclerosis 355
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 353
Validation of the classification criteria for cryoglobulinaemic vasculitis 350
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 347
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 347
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 344
Cardiac Involvement in Systemic Vasculitis 342
Current treatment of hepatitis C-associated rheumatic diseases. 338
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 338
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 337
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 336
Aortic pulse wave velocity measurement in systemic sclerosis patients. 336
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 332
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 329
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 328
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 323
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 322
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 321
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 321
Elevated Troponin Serum Levels in Adult Onset Still's Disease 319
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 319
L-Arginine in pregnant scleroderma patients 317
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 315
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 313
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 309
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 303
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 301
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 299
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 299
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 297
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 297
HCV and cryoglobulinemic vasculitis. 296
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 295
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 294
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 293
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 291
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 289
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 284
Cardiovascular risk and prostanoids in systemic sclerosis 283
Acute exacerbation of interstitial lung disease associated with rheumatic disease 283
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 278
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 278
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 277
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 276
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 275
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? 273
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 273
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 273
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 273
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 272
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 270
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 269
EFFICACIA, SAFETY E TOLLERANZA DI ADALIMUMAB IN PRIMA E SECONDA LINEA IN PAZIENTI CON ARTRITE REUMATOIDE: ESPERIENZA DAI REGISTRI ITALIANI DEI FARMACI BIOLOGICI 269
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 269
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 266
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 266
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 263
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 262
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 262
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 262
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 260
New targeted molecular therapies for dedifferentiated thyroid cancer 259
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 257
Systemic sclerosis following human cytomegalovirus infection 256
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 252
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 251
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 250
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 250
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 249
HCV-related rheumatic manifestations and therapeutic strategies 249
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 249
Treatment of HCV-related mixed cryoglobulinemia 247
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 247
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 247
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases 245
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 245
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 242
Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature 241
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 241
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 238
Totale 44.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 261.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 261.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.542 0 0 0 0 0 0 0 0 0 645 426 471
2021/20225.162 278 415 377 408 239 423 271 312 585 472 748 634
2022/20237.737 676 522 436 487 804 957 523 753 945 354 745 535
2023/20247.596 470 503 547 790 1.025 553 653 868 294 485 599 809
2024/202513.591 705 370 449 972 2.413 1.779 920 700 1.426 881 1.393 1.583
2025/202620.669 1.347 916 1.897 3.068 4.300 1.706 2.732 1.032 2.081 1.590 0 0
Totale 72.782